The growing demand for integrative cancer care reveals gaps in current treatment protocols, with many people turning to unproven or harmful options due to insufficient information and support. Dr HariHaran Kuhan will highlight the potential benefits of Repurposed Medicines and other Metabolically Targeted Interventions. He will discuss difficulties in obtaining valid and reliable research data about these and other integrative options, and suggest some possible strategies to address this. He will also explore the potential benefits of collaborating with public health authorities to facilitate more representative patient populations and more robust research, and emphasise the need to establish reliable, accessible, evidence-based clinical services that incorporate what is already well-established and known about metabolic oncology.